Lexaria Bioscience Stock (NASDAQ: LEXX) stock price, news, charts, stock research, profile.
Open | $2.170 |
Close | - |
Volume / Avg. | 64.077K / 480.650K |
Day Range | 2.170 - 2.260 |
52 Wk Range | 0.649 - 6.850 |
Market Cap | $27.891M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 4% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lexaria Bioscience (NASDAQ: LEXX) through any online brokerage.
Other companies in Lexaria Bioscience’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Lexaria Bioscience (NASDAQ: LEXX) was reported by Maxim Group on Tuesday, March 5, 2024. The analyst firm set a price target for 12.00 expecting LEXX to rise to within 12 months (a possible 454.40% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Lexaria Bioscience (NASDAQ: LEXX) is $2.1645 last updated April 24, 2024 at 5:51 PM EDT.
There are no upcoming dividends for Lexaria Bioscience.
Lexaria Bioscience’s Q3 earnings are confirmed for Friday, July 12, 2024.
There is no upcoming split for Lexaria Bioscience.
Lexaria Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.